169 related articles for article (PubMed ID: 21388071)
1. An unusually large pleural mesothelioma with an outstanding clinical response and long lasting survival: a case report and literature review.
Zilembo N; Vitali M; Pietrantonio F; Platania M; Del Vecchio M; Bajetta E
Tumori; 2010; 96(6):1031-4. PubMed ID: 21388071
[TBL] [Abstract][Full Text] [Related]
2. Successful salvage chemotherapy with gemcitabine and vinorelbine in a malignant pleural mesothelioma patient previously treated with pemetrexed.
Agatsuma T; Koizumi T; Yasuo M; Urushihata K; Tsushima K; Yamamoto H; Hanaoka M; Fukushima M; Honda T; Kubo K
Jpn J Clin Oncol; 2010 Dec; 40(12):1180-3. PubMed ID: 20603247
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
Toyokawa G; Takenoyama M; Hirai F; Toyozawa R; Inamasu E; Kojo M; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
Int J Clin Oncol; 2014 Aug; 19(4):601-6. PubMed ID: 24158772
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Zucali PA; Ceresoli GL; Garassino I; De Vincenzo F; Cavina R; Campagnoli E; Cappuzzo F; Salamina S; Soto Parra HJ; Santoro A
Cancer; 2008 Apr; 112(7):1555-61. PubMed ID: 18286536
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens.
Habib EE; Fahmy ES
Clin Transl Oncol; 2013 Nov; 15(11):965-8. PubMed ID: 23408040
[TBL] [Abstract][Full Text] [Related]
6. [Case of malignant pleural mesothelioma with long-term disease control after 4 different lines of systemic chemotherapy and pleurodesis].
Tanaka A; Takahashi T
Nihon Kokyuki Gakkai Zasshi; 2009 May; 47(5):383-7. PubMed ID: 19514499
[TBL] [Abstract][Full Text] [Related]
7. A pathological complete response in malignant pleural mesothelioma after combination chemotherapy with Carboplatin and pemetrexed.
Kao SC; McCaughan B; Muljono A; Boyer M
J Thorac Oncol; 2010 Mar; 5(3):405-6. PubMed ID: 20186029
[No Abstract] [Full Text] [Related]
8. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
de Perrot M; Feld R; Cho BC; Bezjak A; Anraku M; Burkes R; Roberts H; Tsao MS; Leighl N; Keshavjee S; Johnston MR
J Clin Oncol; 2009 Mar; 27(9):1413-8. PubMed ID: 19224855
[TBL] [Abstract][Full Text] [Related]
9. Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
Pasello G; Nicotra S; Marulli G; Rea F; Bonanno L; Carli P; Magro C; Jirillo A; Favaretto A
Lung Cancer; 2011 Sep; 73(3):351-5. PubMed ID: 21296448
[TBL] [Abstract][Full Text] [Related]
10. Vinca alkaloids in the therapeutic management of malignant pleural mesothelioma.
Ceresoli GL; Zucali PA
Cancer Treat Rev; 2015 Dec; 41(10):853-8. PubMed ID: 26526504
[TBL] [Abstract][Full Text] [Related]
11. [Second-line treatment of malignant pleural mesothelioma with Pemetrexed (Alimta) -- a case report].
Nagel S; Hobrack E; Jehle P; Schütte W
Pneumologie; 2005 Feb; 59(2):108-11. PubMed ID: 15724224
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy options and new advances in malignant pleural mesothelioma.
Steele JP; Klabatsa A
Ann Oncol; 2005 Mar; 16(3):345-51. PubMed ID: 15677623
[TBL] [Abstract][Full Text] [Related]
13. Effective chemotherapy based on a chemosensitivity test for malignant pleural mesothelioma.
Maniwa Y; Yoshimura M; Takata M; Nishimura Y; Ohno Y
Ann Thorac Cardiovasc Surg; 2008 Oct; 14(5):319-21. PubMed ID: 18989249
[TBL] [Abstract][Full Text] [Related]
14. Novel combinations using pemetrexed in malignant mesothelioma.
Gadgeel SM; Pass HI
Clin Lung Cancer; 2004 Apr; 5 Suppl 2():S61-6. PubMed ID: 15117427
[TBL] [Abstract][Full Text] [Related]
15. Disease volumes as a marker for patient response in malignant pleural mesothelioma.
Labby ZE; Nowak AK; Dignam JJ; Straus C; Kindler HL; Armato SG
Ann Oncol; 2013 Apr; 24(4):999-1005. PubMed ID: 23144443
[TBL] [Abstract][Full Text] [Related]
16. Response of a patient with pleural and peritoneal mesothelioma after second-line chemotherapy with lipoplatin and gemcitabine.
Karpathiou G; Argiana E; Koutsopoulos A; Froudarakis ME
Oncology; 2007; 73(5-6):426-9. PubMed ID: 18523361
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
Jänne PA; Simon GR; Langer CJ; Taub RN; Dowlati A; Fidias P; Monberg M; Obasaju C; Kindler H
J Clin Oncol; 2008 Mar; 26(9):1465-71. PubMed ID: 18349397
[TBL] [Abstract][Full Text] [Related]
18. [Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005-2006)].
Margery J; Rivière F; Planchard D; Le Floch H; Ferrand FR; Mairovitz A; Besse B; Vaylet F; Ruffié P
Rev Pneumol Clin; 2010 Sep; 66(4):255-9. PubMed ID: 20933167
[TBL] [Abstract][Full Text] [Related]
19. Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma.
Berardi R; Caramanti M; Fiordoliva I; Morgese F; Savini A; Rinaldi S; Torniai M; Tiberi M; Ferrini C; Castagnani M; Rovinelli F; Onofri A; Cascinu S
Support Care Cancer; 2015 Mar; 23(3):621-6. PubMed ID: 25142706
[TBL] [Abstract][Full Text] [Related]
20. Pemetrexed combination improves mesothelioma survival.
Kerr C
Lancet Oncol; 2005 Aug; 6(8):548. PubMed ID: 16094758
[No Abstract] [Full Text] [Related]
[Next] [New Search]
